76
Views
17
CrossRef citations to date
0
Altmetric
Review

Critical role of tedizolid in the treatment of acute bacterial skin and skin structure infections

, &
Pages 65-82 | Published online: 22 Dec 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Alberto A. Carena & Martin E. Stryjewski. (2020) Tedizolid (torezolid) for the treatment of complicated skin and skin structure infections. Expert Review of Clinical Pharmacology 13:6, pages 577-592.
Read now
Matteo Bassetti, Nadia Castaldo, Alessia Carnelutti, Maddalena Peghin & Daniele Roberto Giacobbe. (2019) Tedizolid phosphate for the treatment of acute bacterial skin and skin-structure infections: an evidence-based review of its place in therapy. Core Evidence 14, pages 31-40.
Read now

Articles from other publishers (15)

Tanner M. Johnson, Thomas F. Byrd, Wendi K. Drummond, Lindsey M. Childs-Kean, Monica V. Mahoney, Jeffrey C. Pearson & Christina G. Rivera. (2023) Contemporary Pharmacotherapies for Nontuberculosis Mycobacterial Infections: A Narrative Review. Infectious Diseases and Therapy 12:2, pages 343-365.
Crossref
Mimi R. Precit, Emily A. Snavely & Rachael M. Liesman. (2022) Don't Be So Negative; Let's Have a Positive Perspective! A Review of Novel Antibiotics Targeting Gram-Positive Bacteria. Clinical Microbiology Newsletter 44:24, pages 219-228.
Crossref
Abdullah Alshememry, Musaed Alkholief, Mohd Abul Kalam, Mohammad Raish, Raisuddin Ali, Sulaiman S. Alhudaithi, Muzaffar Iqbal & Aws Alshamsan. (2022) Perspectives of Positively Charged Nanocrystals of Tedizolid Phosphate as a Topical Ocular Application in Rabbits. Molecules 27:14, pages 4619.
Crossref
Mohd Abul Kalam, Muzaffar Iqbal, Abdullah Alshememry, Musaed Alkholief & Aws Alshamsan. (2022) Fabrication and Characterization of Tedizolid Phosphate Nanocrystals for Topical Ocular Application: Improved Solubilization and In Vitro Drug Release. Pharmaceutics 14:7, pages 1328.
Crossref
Mohd Abul Kalam, Muzaffar Iqbal, Abdullah Alshememry, Musaed Alkholief & Aws Alshamsan. (2022) Development and Evaluation of Chitosan Nanoparticles for Ocular Delivery of Tedizolid Phosphate. Molecules 27:7, pages 2326.
Crossref
Shelanah Fernando, Aryan Shahabi-Sirjani & Thomas Gottlieb. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology 213 229 .
Nur Najihah Izzati Mat Rani, Zahraa Mustafa Hussein, Fahimi Mustapa, Hanisah Azhari, Mahendran Sekar, Xiang Yi Chen & Mohd Cairul Iqbal Mohd Amin. (2021) Exploring the possible targeting strategies of liposomes against methicillin-resistant Staphylococcus aureus (MRSA). European Journal of Pharmaceutics and Biopharmaceutics 165, pages 84-105.
Crossref
Roberto Giurazza, Maria Civita Mazza, Roberto Andini, Pasquale Sansone, Maria Caterina Pace & Emanuele Durante-Mangoni. (2021) Emerging Treatment Options for Multi-Drug-Resistant Bacterial Infections. Life 11:6, pages 519.
Crossref
Alexander A. Bredikhin, Zemfira A. Bredikhina & Aidar T. Gubaidullin. (2020) Chirality-dependent supramolecular synthons based on the 1,3-oxazolidin-2-one framework: chiral drugs mephenoxalone, metaxalone and 114 other examples. CrystEngComm 22:43, pages 7252-7261.
Crossref
Maria de Castro Julve, Paula Miralles Albors, Sara Ortonobes Roig, Roser Vives, Luis Falgueras & Mònica Gómez-Valent. (2020) Hypertensive crisis following the administration of tedizolid: possible serotonin syndrome. European Journal of Hospital Pharmacy 27:1, pages 52-54.
Crossref
Koulenti, Xu, Mok, Song, Karageorgopoulos, Armaganidis, Lipman & SotiriosTsiodras. (2019) Novel Antibiotics for Multidrug-Resistant Gram-Positive Microorganisms. Microorganisms 7:8, pages 270.
Crossref
Yoav Golan. (2019) Current Treatment Options for Acute Skin and Skin-structure Infections. Clinical Infectious Diseases 68:Supplement_3, pages S206-S212.
Crossref
Dee Shortridge & Robert K Flamm. (2019) Comparative In Vitro Activities of New Antibiotics for the Treatment of Skin Infections. Clinical Infectious Diseases 68:Supplement_3, pages S200-S205.
Crossref
Eva J. Katahira, Stephen M. DavidsonDennis L. Stevens & Devin D. Bolz. (2019) Subinhibitory concentrations of tedizolid potently inhibit extracellular toxin production by methicillin-sensitive and methicillin-resistant Staphylococcus aureus. Journal of Medical Microbiology 68:2, pages 255-262.
Crossref
Dana Binyamin, Orna Nitzan, Maya Azrad, Zohar Hamo, Omry Koren & Avi Peretz. (2018) In Vitro Activity of Tedizolid, Dalbavancin, and Ceftobiprole Against Clostridium difficile. Frontiers in Microbiology 9.
Crossref